Xu S - Search Results

1

OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer.

Sun X, Fu X, Xu S, Qiu P, Lv Z, Cui M, Zhang Q, Xu Y. Sun X, et al. Among authors: xu s, xu y. Int Immunopharmacol. 2021 Dec;101(Pt B):108275. doi: 10.1016/j.intimp.2021.108275. Epub 2021 Oct 21. Int Immunopharmacol. 2021. PMID: 34688153

2

Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer.

Xu SP, Zhang JF, Sui SY, Bai NX, Gao S, Zhang GW, Shi QY, You ZL, Zhan C, Pang D. Xu SP, et al. Tumour Biol. 2015 Dec;36(12):9807-12. doi: 10.1007/s13277-015-3746-y. Epub 2015 Jul 10. Tumour Biol. 2015. PMID: 26159853

3

Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.

Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang G, Gao S, You Z, Zhan C, Liu F, Pang D. Xu S, et al. Int J Clin Exp Pathol. 2015 May 1;8(5):4881-91. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191181 Free PMC article.

4

Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.

Lei B, Xu SP, Liang XS, Li YW, Zhang JF, Zhang GQ, Pang D. Lei B, et al. Tumour Biol. 2016 Apr;37(4):5257-64. doi: 10.1007/s13277-015-4360-8. Epub 2015 Nov 10. Tumour Biol. 2016. PMID: 26555546

5

The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.

Xu S, Wang P, You Z, Meng H, Mu G, Bai X, Zhang G, Zhang J, Pang D. Xu S, et al. Oncotarget. 2016 Apr 12;7(15):20704-17. doi: 10.18632/oncotarget.8007. Oncotarget. 2016. PMID: 26980733 Free PMC article.

6

Long Noncoding RNA Linc00152 Functions as a Tumor Propellant in Pan-Cancer.

Xu S, Wan L, Yin H, Xu H, Zheng W, Shen M, Zhang Z, Pang D. Xu S, et al. Among authors: xu h. Cell Physiol Biochem. 2017;44(6):2476-2490. doi: 10.1159/000486170. Epub 2017 Dec 18. Cell Physiol Biochem. 2017. PMID: 29268251 Free article.

7

Hypoxia-Induced TPM2 Methylation is Associated with Chemoresistance and Poor Prognosis in Breast Cancer.

Zhang J, Zhang J, Xu S, Zhang X, Wang P, Wu H, Xia B, Zhang G, Lei B, Wan L, Zhang D, Pang D. Zhang J, et al. Among authors: xu s. Cell Physiol Biochem. 2018;45(2):692-705. doi: 10.1159/000487162. Epub 2018 Jan 31. Cell Physiol Biochem. 2018. PMID: 29414807 Free article.

8

Landscape of tumor suppressor long noncoding RNAs in breast cancer.

Pang B, Wang Q, Ning S, Wu J, Zhang X, Chen Y, Xu S. Pang B, et al. Among authors: xu s. J Exp Clin Cancer Res. 2019 Feb 14;38(1):79. doi: 10.1186/s13046-019-1096-0. J Exp Clin Cancer Res. 2019. PMID: 30764831 Free PMC article.

9

Long noncoding RNA FER1L4 acts as an oncogenic driver in human pan-cancer.

You Z, Ge A, Pang D, Zhao Y, Xu S. You Z, et al. Among authors: xu s. J Cell Physiol. 2020 Feb;235(2):1795-1807. doi: 10.1002/jcp.29098. Epub 2019 Jul 22. J Cell Physiol. 2020. PMID: 31332783

10

Noncoding RNAs: the shot callers in tumor immune escape.

Liu L, Wang Q, Qiu Z, Kang Y, Liu J, Ning S, Yin Y, Pang D, Xu S. Liu L, et al. Among authors: xu s. Signal Transduct Target Ther. 2020 Jun 19;5(1):102. doi: 10.1038/s41392-020-0194-y. Signal Transduct Target Ther. 2020. PMID: 32561709 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,330 results

Search Page

Filters